Santa Ana Bio
- Website
- santaanabio.com
- Total Funding
- $168.0M
- Last Round
- $43.0M Series AJun 2024
- Rounds
- 2
About
Developing engineered antibody therapies for selective targeting and depletion of immune cells
Summary
Santa Ana Bio is an Artificial Intelligence company. It has raised $168.0M in total across 2 rounds, most recently a $43.0M Series A round in Jun 2024. Investors include GV, Jerel Davis and TPG (Growth/Rise).
Tech & App Stack
6 technologies & apps tracked
Create a free account — 10 credits a month to unlock the full tech & app stack, funding history, and valuations.
Sign up to view the funding chart
Create a free account — you'll get 10 credits a month to unlock funding history, valuations, and tech stacks.
Funding History
Jun 2024
Sign up to see all 2 rounds
Full funding history, per-round amounts, and investor participation.
Investors
Similar Companies
Next-gen Medicare Advantage insurance plan with AI-forward medical group delivering quality and s...
OpenAI is an AI research and deployment company dedicated to ensuring that general-purpose artifi...
Anthropic is an AI research company that builds reliable, interpretable, and steerable AI systems.
xAI is an AI platform for accelerating human scientific discovery.
Largest private manufacturer and distributor of medical-surgical products serving healthcare prov...
Waymo is an autonomous driving technology company with a mission to make it safe and easy for peo...